Pigs.

Active immunisation of pigs from the age of 8 weeks onwards against pandemic H1N1 porcine influenza virus to reduce viral lung load and viral excretion.

Onset of immunity: 7 days after primary vaccination.

Duration of immunity: 3 months after primary vaccination.

None

Vaccinate healthy animals only.

Not applicable.

In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.

A transient increase in rectal temperature, not exceeding 2 °C, is common after vaccination and this does not persist for more than one day. A transient swelling up to 2 cm3 may occur at the site of injection: these reactions are common but resolve within 5 days.

Can be used during pregnancy and lactation.

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

For intramuscular use.

Vaccination: 2 injections of one dose (1 ml) from the age of 56 days, with an interval of 3 weeks between injections.

The efficacy of revaccination has not been investigated and therefore no revaccination schedule is proposed.

Maternally-derived antibodies in piglets interfere with the Respiporc FLUpan H1N1 mediated immunity. Generally, maternally-derived antibodies induced by vaccination last for approximately 5–8 weeks after birth. In cases of exposure of the sows to antigens (from either field infections and/or vaccination) the antibodies transmitted to the piglets can interfere with active immunisation at 12 weeks of age. In such cases the piglets should be vaccinated after the age of 12 weeks.

None known.

Zero days.